Author's posts
Majority of patients maintain weight loss after stopping medication, study reveals
After discontinuing the use of semaglutide and liraglutide weight-loss medications, a majority of patients were able to maintain the same weight they were at when halting the use — or even continued to lose additional weight after one year, a new study…
900+ chemicals in consumer products tied to breast cancer risk, study says
Researchers have identified 921 chemicals thought to increase the risk of breast cancer and say none should be considered “low hazard” until further investigation is done.
CHI St. Vincent taps hospital president
Megan Bonney is the new president of CHI St. Vincent North, a hospital in Sherwood, Ark.
Medical scrubs company Careismatic files for bankruptcy
Careismatic, a medical scrubs maker and distributor in California, filed for bankruptcy Jan. 23 as it logs $833 million in debt, according to The Wall Street Journal.
Cedars-Sinai AI tool accurately detects pancreatic cancer
Los Angeles-based Cedars-Sinai is using artificial intelligence to improve prediction of and treatment for pancreatic cancer, according to a Jan. 22 news release.
25 physician specialties with the most burnout
Burnout and depression have fallen 4 percentage points and 3 percentage points, respectively, in the last year, according to a Jan. 24 Medscape report.
Bon Secours Mercy Health hit with data breach lawsuit
Cincinnati-based Bon Secours Mercy Health is the latest big health system to face a lawsuit over a data breach involving a medical transcription vendor.
Cleveland Clinic, IBM publish 1st AI findings
Cleveland Clinic and IBM published the first findings from their artificial intelligence partnership, showing how the technology could help cancer patients.
Instacart expands services to home care
Instacart is partnering with DispatchHealth, a provider of in-home medical care, to give patients receiving home care access to nutritious foods.
J&J to settle talc powder probe for $700M
Johnson & Johnson has tentatively agreed to settle a sweeping probe over its marketing of talcum-based baby powder for about $700 million, a company executive told The Wall Street Journal.
